Centogene announced that it received a notification letter from Nasdaq indicating that the company was not in compliance with the minimum bid price requirement set forth in Rule 5450(a)(1) of the Nasdaq Listing Rules since the closing bid price for the company’s common shares listed on Nasdaq was below $1.00 for 30 consecutive business days. Nasdaq Rule 5450(a)(1) requires the shares to maintain a minimum bid price of $1.00 per share, and Nasdaq Rule 5810(c)(3)(A) provides that failure to meet such a requirement exists when the bid price of the shares is below $1.00 for a period of 30 consecutive business days.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTG:
- Centogene N.V. Faces Nasdaq Compliance Challenge
- CENTOGENE Receives Nasdaq Non-Compliance Notice
- CENTOGENE and Takeda Boost Genetic Testing for LSDs
- CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
- Centogene extends partnership with Takeda